000			01941 a2200553 4500
005			20250513190746.0
264		0	_c19990921
008			199909s 0 0 eng d
022			_a1042-8194
024	7		_a10.3109/10428199909050955 _2doi
040			_aNLM _beng _cNLM
100	1		_aDelain, M
245	0	0	_aIntensive therapy with autologous stem cell transplantation as first-line therapy in poor-risk Hodgkin's disease and analysis of predictive factors of outcome. _h[electronic resource]
260			_bLeukemia & lymphoma _cJul 1999
300			_a305-13 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBleomycin _xtherapeutic use
650	0	4	_aDisease-Free Survival
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aEtoposide _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHematopoietic Stem Cell Transplantation
650	0	4	_aHodgkin Disease _xtherapy
650	0	4	_aHumans
650	0	4	_aIfosfamide _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMechlorethamine _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aMitoguazone _xtherapeutic use
650	0	4	_aOutcome Assessment, Health Care
650	0	4	_aPrednisolone _xtherapeutic use
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aProcarbazine _xtherapeutic use
650	0	4	_aPrognosis
650	0	4	_aProspective Studies
650	0	4	_aVinblastine _xanalogs & derivatives
650	0	4	_aVincristine _xtherapeutic use
700	1		_aCartron, G
700	1		_aBout, M
700	1		_aBenboubker, L
700	1		_aLinassier, C
700	1		_aLamagnere, J P
700	1		_aColombat, P
773	0		_tLeukemia & lymphoma _gvol. 34 _gno. 3-4 _gp. 305-13
856	4	0	_uhttps://doi.org/10.3109/10428199909050955 _zAvailable from publisher's website
999			_c10397127 _d10397127